Ending the Epidemic Interventions in the Dental Setting - UH3
ETE
Effectiveness of Comprehensive Ending the Epidemic (ETE) Interventions in the Dental Setting
2 other identifiers
interventional
128
1 country
3
Brief Summary
The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedStudy Start
First participant enrolled
March 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
July 23, 2025
July 1, 2025
2.4 years
March 14, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients that complete point of care HIV testing out of patient encounters receiving clinical decision support (CDS) prompts for HIV testing
Proportion of patients receiving clinical decision support (CDS) prompts for HIV testing that complete point of care HIV testing over the intervention period under the Enhanced versus Standard Dental Care Models.
10 months after start of each arm
Secondary Outcomes (5)
Provider acceptability of multicomponent HIV service package in dental clinics
5-10 months after start of each arm
Provider feasibility of multicomponent HIV service package in dental clinics
5-10 months after start of each arm
Proportion of patients receiving CDS prompt for HIV testing that complete subsequent HIV testing outside of the dental clinic
Within 12 months following dental visit
Proportion of patients receiving CDS prompt for HIV testing with subsequent appointment at an HIV prevention clinic
Within 12 months following dental visit
Proportion of patients receiving CDS prompt for HIV testing subsequently prescribed pre-exposure prophylaxis (PrEP) medication
Within 12 months following dental visit
Study Arms (2)
Standard Dental Care Team model
PLACEBO COMPARATORMulticomponent HIV Service Package delivered without a Care Navigator
Enhanced Dental Care Team model with a Care Navigator
EXPERIMENTALMulticomponent HIV Service Package delivered with a Care Navigator
Interventions
The Care Navigator will be added to the dental team as an added resource to: 1. Champion the use of the multicomponent HIV intervention in the dental clinic among clinic administrators, residents, dental hygienists, dental assistants, and other dental team staff. 2. Provide technical assistance 3. Provide logistical assistance ; and 4. Support dental team in educating patients about HIV prevention and treatment options
Multicomponent HIV Service Package consisting of: 1. Clinical Decision Support (CDS) within electronic medical record (EMR) system to help providers identify patients who would benefit from HIV screening or re-engagement in HIV care. 2. Point-of-care HIV testing in the dental clinic. 3. Patient and provider-facing educational materials to support providers in discussing HIV prevention options (for patients who test HIV negative) and treatment (for patients who test HIV positive or are out of HIV care) options.
Eligibility Criteria
You may qualify if:
- Member of the Dental Team (Provider, Hygienist, Dental Assistant, Care Navigator) at one of the randomized sites with direct patient contact
- Able to provide written informed consent.
You may not qualify if:
- \- Inability to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
New York, New York, 10032, United States
Weill Cornell Medical Center / NewYork-Presbyterian Hospital
New York, New York, 10065, United States
NYP-Queens
Queens, New York, 11365, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
March 14, 2025
First Posted
March 24, 2025
Study Start
March 31, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
De-identified participant data may be shared with other researchers within Columbia University at the discretion of the Principal Investigator, and only when the Institutional Review Board (IRB) approval has been granted to allow for the sharing of such data.